BridgeMD
New treatment option for Alcohol Dependence
Official title High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction
ClinicalTrials.gov ID: NCT05738174
What this study is testing
- What it's testing
- This is a two-arm randomized placebo-controlled trial in which 72 patients with alcohol addiction are treated with high-dose accelerated intermittent theta burst stimulation (TBS).
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- alchohol dependence according to ICD-10 (F10.2)
- desire to reduce or abstain from alcohol drinking
- male or female
- 18-65 years
- residency in Germany, German speaking
You likely can't join if
- contraindications for transcranial magnetic stimulation (electric devices or metal parts in the body such as pacemaker)
- relevant neurological or internistic diseases according to study investigator
- treatment with TMS in the past
- participation in other trials during treatment
- pregnancy or breatfeeding
- positive breath test for alcohol
See the full eligibility criteria
- alchohol dependence according to ICD-10 (F10.2)
- desire to reduce or abstain from alcohol drinking
- male or female
- 18-65 years
- residency in Germany, German speaking
- written informed consent
- contraindications for transcranial magnetic stimulation (electric devices or metal parts in the body such as pacemaker)
- relevant neurological or internistic diseases according to study investigator
- treatment with TMS in the past
- participation in other trials during treatment
- pregnancy or breatfeeding
- positive breath test for alcohol
- legal care and placement in a psychiatric hospital
- co-medication with disulfiram, acamprosate, topiramate, baclofen, naltrexone, or nalmefene
- acute psychiatric comorbidity that requires inpatient treatment or medication readjustment (\<1 month)
- severe chronic psychiatric illness (schizophrenia, schizoaffective disorder, bipolar disorder)
- patients who are unable to complete study questionnaires or follow-up questionnaires (in the opinion of the investigators)
The study team makes the final eligibility decision.
Where it's taking place
- Regensburg, Germany
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Regensburg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.